Skip to search formSkip to main contentSkip to account menu

CHOP protocol-cyclophosphamide/doxorubicin/prednisone/vincristine

Known as: CTX/DOX/PRED/VCR, ACOP, cyclophosphamide, doxorubicin, prednisone, and vincristine protocol 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
BACKGROUND The long-term prognosis for older patients with mantle-cell lymphoma is poor. Chemoimmunotherapy results in low rates… 
Highly Cited
2010
Highly Cited
2010
To evaluate outcome and prognosis of patients with T-cell lymphoma we analyzed 343 patients treated within trials of the German… 
Highly Cited
2007
Highly Cited
2007
PURPOSE Our previous phase II trial for treating human T-lymphotropic virus type I-associated adult T-cell leukemia-lymphoma… 
Highly Cited
2006
Highly Cited
2006
We evaluated the role of rituximab (R) both in remission induction and maintenance treatment of relapsed/resistant follicular… 
Highly Cited
2005
Highly Cited
2005
PURPOSE To analyze the long-term outcome of patients included in the Lymphome Non Hodgkinien study 98-5 (LNH98-5) comparing… 
Highly Cited
2003
Highly Cited
2003
In diffuse large B-cell lymphoma (DLBCL), the combination of rituximab and CHOP (cyclophosphamide, doxorubicine, vincristine… 
Highly Cited
2000
Highly Cited
2000
The copA gene product, a putative copper-translocating P-type ATPase, has been shown to be involved in copper resistance in… 
Highly Cited
1991
Highly Cited
1991
  • J. Cha, D. Cooksey
  • Proceedings of the National Academy of Sciences…
  • 1991
  • Corpus ID: 38086653
Copper-resistant strains of Pseudomonas syringae pathovar tomato accumulate copper and develop blue colonies on copper-containing…